Caliway Biopharmaceuticals Market Cap

Caliway Biopharmaceuticals has a market cap or net worth of 90.07 billion as of January 3, 2025. Its market cap has increased by 285.14% in one year.

Market Cap

90.07B

Enterprise Value

80.39B

Revenue

49.98M

Ranking

n/a

PE Ratio

n/a

Stock Price

587.00

Market Cap Chart

Since December 26, 2022, Caliway Biopharmaceuticals's market cap has increased from 7.96B to 90.07B, an increase of 1,031.74%. That is a compound annual growth rate of 231.48%.

Market Cap History

Date	Market Cap	% Change
Jan 3, 2025	90.07B	-4.55%
Dec 31, 2024	94.36B	300.87%
Dec 29, 2023	23.54B	212.69%
Dec 30, 2022	7.53B	-5.41%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	205.06B
Bora Pharmaceuticals Co., LTD.	77.20B
Lotus Pharmaceutical	70.20B
Oneness Biotech	40.01B
Lumosa Therapeutics	39.86B
Polaris Group	34.14B
Center Laboratories	31.01B
Pegavision	29.95B

Market Cap Rankings